Patient Monitoring Market

Patient Monitoring Market Size (2023 to 2028)

The global patient monitoring market size was estimated at USD 30.14 Billion in 2023 and worth USD 43.27 Billion by 2028, showcasing a CAGR of 7.5% from 2023 to 2028.

Patient Monitoring Market Share Insights:

• Based on the application, the multi-parameter monitoring devices segment had the leading global patient monitoring market share and accounted for a market share of 26.8% in 2022.
• North America was the largest regional market globally in 2022 and accounted for a market share of 39.6% of the global market in 2022.
• The Europe patient monitoring market occupied the second-largest share of the global market in 2022.

MARKET DRIVERS:

The growing incidence of chronic diseases and the aging population, as the increasing adoption of home healthcare and remote patient monitoring, are accelerating the growth of the global patient monitoring market.

Wearable medical monitoring devices, biosensors, and smart implants are used for various purposes, including continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things is built into the first generation of wearable gadgets. Wearable biosensors monitor vital signs, including blood pressure, weight, blood sugar, and electrocardiography (ECG), then send them to a central server through mobile wireless networks. Increased prevalence of patients suffering from various lifestyle disorders such as diabetes, cancer, atherosclerosis, and an uptick in online patient tracking systems. Collaborations between companies, hospitals, and universities are likely to result in the release of new devices and increased recognition and acceptance of such utilities by physicians and healthcare professionals. Various advantages of continuous patient monitoring systems, such as lower ICU usage, shorter hospital stays, and a simple warning system, would propel the patient monitoring market forward.

The increasing demand for patient monitoring devices in hospitals and non-hospital settings provides growth opportunities to the market. In addition, rising investments in developing advanced featured devices in the medical sector are promoting the growth of the patient monitoring market. Also, emerging markets in different regions offer opportunities for players to enter the patient monitoring market.

MARKET RESTRAINTS:

However, the risks associated with patient monitoring devices hinder the overall growth of the global patient monitoring market. In addition, the shortage of skilled persons to operate the devices is another major factor impeding the market growth.

REPORT COVERAGE:

This research report on the global patient monitoring market has been segmented and sub-segmented based on the application and region.

Patient Monitoring Market - By Application:

• Neuromonitoring Devices
  • Electroencephalograph (EEG)
  • Transcranial Doppler (TCD)
  • Magnetoencephalography (MEG)
  • Cerebral Oximeters
  • Intracranial Pressure Monitors (ICP)
• Hemodynamic Monitoring Devices
  • Blood Pressure Monitors
  • Blood Glucose Monitors
  • Blood Gas and Electrolyte Analyzers
  • Cholesterol Analyzers
• Cardiac Monitoring Devices             
  • Electrocardiogram (ECG) 
  • Event Monitors
  • Implantable Loop Recorder (ILR) 
  • Cardiac Output Monitoring Devices 
• Fetal and neonatal Monitoring Devices      
  • Ultrasound Fetal Dopplers 
  • Internal Fetal Monitors
• Respiratory Monitoring Devices     
  • Capnography 
  • Spirometers 
  • Anesthesia Monitors 
  • Sleep Apnea Monitoring Devices 
  • Pulse Oximeters
• Multi-Parameter Monitoring Devices          
  • High-Acuity Monitors 
  • Mid-Acuity Monitors 
  • Low-Acuity Monitors
• Temperature Monitoring Devices 
• Weight Monitoring Devices             
• Remote Patient Monitoring Devices          

Based on the application, the multi-parameter monitoring devices segment led the patient monitoring market in 2022 and accounted for the largest market share in 2021.

The neuromonitoring devices segment is anticipated to grow at a promising CAGR during the forecast period. Under this segment, EEG machines are the segment to account for the largest share of the neuromonitoring devices market in 2022 and are expected to maintain this trend during the forecast period. Due to the growing incidence and prevalence of neurological disorders, increasing research and development in cerebral and spinal disorders, and the increasing number of EEG Labs and sleep centers.

The respiratory monitoring devices are subdivided into pulse oximeters, capnography, spirometers, and peak flow meters. The capnography segment is anticipated to show the highest growth rate during the forecast period. It is mainly due to the compulsory anesthesia provision of these instruments and the patients & respiratory condition monitoring in ICUs.

Patient Monitoring Market - By Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East & Africa

Geographically, the patient monitoring market in North America accounted for the most significant share of the global market in 2022. The significant factors backing the market's growth in this region are the aging population and increased lifestyle diseases that further serve the overall prevalence of chronic diseases followed by Europe. However, these regions' growth is expected to be slow in the forecast period due to decreasing birth rates, irregular reimbursement policies, and a reduced number of beds in hospitals.

The patient monitoring market in Europe is estimated to be a CAGR of 7.10% from 2022 to 2027.

The patient monitoring market in Asia Pacific is projected to grow at the highest CAGR over the forecast period. Asia-Pacific is the most favorable and promising region for patient monitoring devices in the coming few years. The improved purchasing power of patients and a high population base are the major drivers propelling the market in this region. Besides, the economic instability in the western countries facilitates the companies to plan their business more in the Asia-Pacific region and meet their revenue targets. On the flip side, patient privacy concerns & lack of proper reimbursement policies, and the high cost of Patient Monitoring systems inhibit the market's growth.

The Latin American patient monitoring market is growing steadily. Factors such as the growing patient count suffering from chronic diseases, the rising number of surgeries being performed, and the increasing demand for patient monitoring devices in the Latin American region promote regional market growth.

The Patient Monitoring market in the Middle East & Africa is predicted to register a CAGR of 7.69% during the forecast period.

KEY MARKET PARTICIPANTS:

Some of the prominent companies dominating the global patient monitoring market profiled in the report are Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn.

RECENT MARKET HAPPENINGS:

• Medtronic obtained FDA and CE 510(k) approvals for their LINQ II Insertable Cardiac Monitor in July 2020. (ICM). The LINQ II is a tiny wireless ICM designed for individuals with irregular cardiac rhythms that need long-term monitoring. BlueSync technology allows remote patient monitoring and data transmission via the MyCareLink Heart smartphone app or the MyCareLink Relay home communicator.
• Masimo Corporation bought NantHealth's linked care business in 2020, bolstering its position in the connected care industry.
• Medtronic and Tandem Diabetic Care, Inc signed a patent cross-license deal in 2020, allowing the two firms to cross-license each other's patent portfolio for five years while focusing on developing innovative diabetes products and services together.
• Abbott gained FDA approval for the FreeStyle Libre 2 Integrated Continuous Glucose Monitoring (iCGM) device for diabetic patients in June 2020.
• In March 2020, GE Healthcare and Ford Motor Company teamed up to increase the manufacturing of ventilators, giving physicians the tools they need to treat COVID-19 patients.
• Biotronik announced the launch of BioMonitor III, an injectable cardiac monitor (ICM), in Japan in January 2020. The gadget was created to aid patients with abnormal heart rhythms by better recording unexplained syncope.
• Royal Philips increased the manufacturing in March 2020 of specific critical care goods and solutions that aid the detection and treatment of COVID-19 patients.
• In Early 2015, Roche and Qualcomm announced their collaboration. It is a strategic move to innovate and improve remote monitoring and ensure proper management of chronic disease patients.